Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN1 | Q9GZT9 | 16/20 | 0.77 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | AADAT | Q8N5Z0 | 1/20 | 0.44 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3371427 | 0.87 | EGLN1 (1.00) | EGLN1LMNAHPGD | |
| SCHEMBL3368993 | 0.86 | EGLN1 (0.85) | EGLN1 | |
| SCHEMBL3371732 | 0.85 | EGLN1 (0.83) | EGLN1KMT2A | |
| SCHEMBL3371812 | 0.85 | EGLN1 (0.82) | EGLN1KMT2A | |
| SCHEMBL3369212 | 0.85 | EGLN1 (0.82) | EGLN1LMNAHPGD | |
| SCHEMBL3367958 | 0.84 | EGLN1 (0.77) | EGLN1LMNAHPGD | |
| SCHEMBL3367973 | 0.83 | EGLN1 (0.84) | EGLN1LMNAHPGD | |
| SCHEMBL3367838 | 0.82 | EGLN1 (0.83) | EGLN1 | |
| SCHEMBL3367688 | 0.82 | EGLN1 (0.83) | EGLN1LMNAHPGD | |
| SCHEMBL3369074 | 0.82 | EGLN1 (1.00) | EGLN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010018458-A2 | PHENOL DERIVATIVES AND METHODS OF USE THEREOF | CRYSTALGENOMICS, INC. (KR) | 2010-02-18 | — | — | WO | claimed |
| WO-2010018458-A2 | PHENOL DERIVATIVES AND METHODS OF USE THEREOF | CRYSTALGENOMICS, INC. (KR) | 2010-02-18 | — | — | WO | disclosed |